Therefore, we first set out to investigate the underlying changes in healthy control APOE genotypes  (i.e. E2/E2, E3/E3, and E4/E4) to determine whether underlying isoform specific differences exist in non-demented patients that could be prodromal to and contribute to AD pathogenesis. Here, APOE is linked to Alzheimer disease.